TOP STORIES

• REGULATORY Japan Approves Batch of New Drugs, Subcutaneous Rybrevant Finally Cleared
  December 23, 2025

• TRENDS Top 10 PHARMA JAPAN Articles of 2025
  December 23, 2025

• REGULATORY LDP, Ishin Strike Deal on OTC-Like Drugs, Patients to Pay “1/4” Special Charge
  December 22, 2025

• REGULATORY LDP, Ishin Finalize FY2026 Tax Reform Outline, Strategic Tech R&D Credit Codified
  December 22, 2025

• BUSINESS Sanofi Bets on Immunotherapy to Delay Onset of Type 1 Diabetes
  December 19, 2025

• REGULATORY LDP, Ishin Fail to Seal Deal on OTC-Like Drugs as Talks Stall over Fiscal-Savings Figure
  December 18, 2025

• BUSINESS AI-Driven Target Discovery Gains Ground among Japanese Pharma: FRONTEO CEO
  December 17, 2025

• ORGANIZATION Pharma Groups Reiterate “No” to Broader CEA Use, Huge-Seller and Spillover Rules: Joint Statement
  December 17, 2025

• BUSINESS Pfizer Targets Double-Digit Oncology Growth in Japan over Next 5 Years
  December 16, 2025

• REGULATORY Chuikyo Backs Draft FY2026 Pricing Reform Outline, Rejects Key Industry Requests
  December 15, 2025

• REGULATORY LDP Tax Panel OKs New 40% R&D Credit for Strategic Technologies
  December 12, 2025

• BUSINESS AG Price Parity Plan Stokes Industry Fears of Patient, Pharmacy Defections
  December 12, 2025

• REGULATORY Pharma Renews Call to Scrap “Spillover,” “Huge-Seller” Rules as FY2026 Talks Enter Final Stretch
  December 11, 2025

• BUSINESS Regeneron Lines Up 5 Late-Stage Assets for Japan: Commercial Head
  December 11, 2025

• BUSINESS Asahi Kasei Pharma Confident of Hitting FY2030 Group Sales Target: President
  December 10, 2025

• BUSINESS LinqMed Builds Radiopharma Plant in Rare Manufacturing Bet for Biotech Startup
  December 9, 2025

• REGULATORY PMDA to Adopt General-Purpose AI in FY2025, Eyes Specialized Tools for Reviews and Safety Work
  December 8, 2025

• REGULATORY Japan Likely to Extend Generic-Name Prescribing Premium to Biologics to Spur Biosimilars
  December 8, 2025

• REGULATORY R&D Tax Credit Draws Broad Calls for Maintenance, Expansion: LDP Meeting
  December 8, 2025

• REGULATORY Forxiga, Zytiga Seen Taking Biggest Hit by PMP Returns in FY2026
  December 5, 2025

ページ

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »